Palvella Therapeutics Inc (PVLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Sales | 1,877 | 2,939 | 11,246 | 13,261 | 17,270 |
| Gross Profit | 1,877 | 2,939 | 11,246 | 13,261 | 17,270 |
| Operating Expenses | 14,288 | 15,938 | 15,901 | 17,117 | 18,600 |
| Operating Income | -12,411 | -12,999 | -4,655 | -3,856 | -1,330 |
| Other Income | -1,825 | -1,284 | -295 | 259 | 559 |
| Pre-tax Income | -14,236 | -14,283 | -4,950 | -3,597 | -771 |
| Net Income Continuous | -14,400 | -14,283 | -4,950 | -3,597 | -771 |
| Net Income | $-14,400 | $-14,283 | $-4,950 | $-3,597 | $-771 |
| EPS Basic Total Ops | -20.80 | -20.80 | -7.20 | -5.60 | -5.60 |
| EPS Basic Continuous Ops | -20.87 | -21.03 | -7.56 | -5.21 | -0.66 |
| EPS Diluted Total Ops | -20.80 | -20.80 | -7.20 | -5.60 | -5.60 |
| EPS Diluted Continuous Ops | -20.87 | -21.03 | -7.56 | -5.21 | -0.66 |
| EBITDA(a) | $-11,723 | $-12,245 | $-4,125 | $-3,517 | $-1,065 |